Orthocell Limited (OCC.AX)

AUD 1.25

(-0.4%)

Operating Expenses Summary of Orthocell Limited

  • Orthocell Limited's latest annual operating expenses in 2024 was 15.36 Million AUD , up 14.95% from previous year.
  • Orthocell Limited's latest quarterly operating expenses in 2024 FY was 15.33 Million AUD , up 14.71% from previous quarter.
  • Orthocell Limited reported a annual operating expenses of 13.37 Million AUD in annual operating expenses 2023, up 8.2% from previous year.
  • Orthocell Limited reported a annual operating expenses of 12.35 Million AUD in annual operating expenses 2022, up 3.24% from previous year.
  • Orthocell Limited reported a quarterly operating expenses of 7.73 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Orthocell Limited reported a quarterly operating expenses of 7.66 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Orthocell Limited (2024 - 2013)

Historical Annual Operating Expenses of Orthocell Limited (2024 - 2013)

Year Operating Expenses Operating Expenses Growth
2024 15.36 Million AUD 14.95%
2023 13.37 Million AUD 8.2%
2022 12.35 Million AUD 3.24%
2021 11.96 Million AUD 26.48%
2020 9.46 Million AUD 9.98%
2019 8.6 Million AUD 5.23%
2018 8.17 Million AUD 30.77%
2017 6.25 Million AUD 13.21%
2016 5.52 Million AUD 7.01%
2015 5.16 Million AUD 82.9%
2014 2.82 Million AUD 103.02%
2013 1.39 Million AUD 0.0%

Peer Operating Expenses Comparison of Orthocell Limited

Name Operating Expenses Operating Expenses Difference
EZZ Life Science Holdings Limited 39.57 Million AUD 61.163%
Anatara Lifesciences Ltd 710.21 Thousand AUD -2064.063%
Zelira Therapeutics Limited 5.94 Million AUD -158.376%
Biome Australia Limited 7.91 Million AUD -94.275%
Patrys Limited 4.93 Million AUD -211.546%
Imugene Limited 135.09 Million AUD 88.623%
Noxopharm Limited 7 Million AUD -119.559%
PYC Therapeutics Limited 60.91 Million AUD 74.77%
Chimeric Therapeutics Limited 19.76 Million AUD 22.248%
Prescient Therapeutics Limited 10.89 Million AUD -41.021%
Proteomics International Laboratories Limited 892.14 Thousand AUD -1622.767%
Cynata Therapeutics Limited 11.12 Million AUD -38.171%
CSL Limited 7.56 Billion AUD 99.797%
Arovella Therapeutics Limited 10.78 Million AUD -42.505%
Bio-Gene Technology Limited 2.76 Million AUD -456.663%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 50.891%
Starpharma Holdings Limited 22.81 Million AUD 32.637%
Nanollose Limited 12.5 Thousand AUD -122846.492%
Memphasys Limited 3.67 Million AUD -317.834%
Invex Therapeutics Ltd 3.34 Million AUD -359.357%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -682.077%
Amplia Therapeutics Limited 8.43 Million AUD -82.196%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -2453.844%
Island Pharmaceuticals Limited 4.12 Million AUD -272.563%
Race Oncology Limited 14.77 Million AUD -4.056%
Nyrada Inc. 4.55 Million AUD -237.409%
Telix Pharmaceuticals Limited 269.26 Million AUD 94.292%
Dimerix Limited 25.64 Million AUD 40.064%
PharmAust Limited 6.65 Million AUD -130.878%
Immutep Limited 42.87 Million AUD 64.153%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 72.704%
Alterity Therapeutics Limited 23.4 Million AUD 34.337%
BTC Health Limited -1.03 Million AUD 1579.367%
Acrux Limited 8.55 Million AUD -79.761%
Neuren Pharmaceuticals Limited 32.69 Million AUD 52.994%
Biotron Limited 5.11 Million AUD -200.734%
Tissue Repair Ltd 6.66 Million AUD -130.538%
AdAlta Limited 6.76 Million AUD -127.041%
Radiopharm Theranostics Limited 299.22 Thousand AUD -5036.398%
Hexima Limited 1 Million AUD -1423.622%
AnteoTech Limited 12.18 Million AUD -26.114%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 76.392%
Recce Pharmaceuticals Ltd 21.68 Million AUD 29.122%
Avecho Biotechnology Limited 4.54 Million AUD -238.134%
Actinogen Medical Limited 22.77 Million AUD 32.502%
Immuron Limited 9.13 Million AUD -68.195%
Argenica Therapeutics Limited 8.26 Million AUD -85.866%